Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Seagen, Genmab See Broad Cervical Cancer Opportunity For Tisotumab Vedotin
US FDA Clears Monotherapy Use
20 Sep 2021
•
By
Joseph Haas
Seagen's ADC Tivdak, partnered with Genmab, obtains US approval, positions for other indications
More from Clinical Trials
More from R&D